Last 5 years6,046 documents Updated 18 Aug

Takeda Pharmaceutical Company Limited

Overview · What matters about Takeda right now?

Research

What is being built

Documents by area

  • 1597
  • 1055
  • 1030
  • 1007
  • 877
  • 443

What's new · What is newest about Takeda?

Research · What is Takeda building?

Where the work is growing

Dot size: documents that year
Where the work is growing
Area2021 2022 2023 2024 2025 2026 so farTotal
1597
1055
1030
1007
877
443

What problems are they working on?

Size and shade: documents

Largest 15 of 134 problems

Latest in innovation

Di-aliphatic substituted pegylated lipids Patent · Alnylam Pharmaceuticals Heterocyclic NMDA antagonists Patent · Takeda Hematopoietic progenitor cell marker Patent · Kyoto University Uses of an adamts13 composition for treating, improving or preventing vaso-occlusive crisis Patent · Takeda Particle prevention adapter system for injection pen Patent · Takeda

Strategy · Where is Takeda putting its money and effort?

How far along each area is

Innovation Market · Not available A year ago
How far along each area is

Money, launches and partners

Market news · Not available. News wasn't included when this radar was set up.

Partnerships

Polynucleotide molecules, immunogenic pharmaceuticals and preparations containing these polynucleotide molecules and related vectors and cell lines Patent · Takeda, US Department of Health and Human Services · Method for producing cardiac muscles Patent · Kyoto University, Takeda · Crystalline forms of n-(4-(1-(2,6-difluorobenzyl)-5-((dimethylamino)methyl)-3-(6-methoxy-3-pyridazinyl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl)phenyl)-n'-methoxyurea Patent · Sumitomo Pharma, Takeda · T-cell receptor modified object Patent · Kyoto University, Takeda · Compound, α-synuclein aggregate binder, and use thereof Patent · National Institute For Quantum Science And Technology, Eisai, Ono Pharmaceutical, Takeda · Treatment of prostate cancer Patent · Sumitomo Pharma, Takeda · Di-aliphatic substituted pegylated lipids Patent · Alnylam Pharmaceuticals, Takeda · Hematopoietic progenitor cell marker Patent · Kyoto University, Takeda · Method for producing T progenitor cells Patent · Kyoto University, Takeda ·

New to this radar

Dengue vaccination Knowledge, Attitudes, and Practices among healthcare providers in selected countries from Latin America and Asia Pacific Paper · Centro Peruano de Estudios Sociales · A high-throughput platform for biophysical antibody developability assessment to enable AI/ML model training Paper · Ginkgo BioWorks, Instituto de Arqueología-Mérida, eBOS Technologies · Cell and Gene Therapy: Transforming Treatment Paradigms for Patient‐Centric Care Paper · Biocon · Synthesis of cyclopropane carboxylic acids Patent · Andreas Rennhack, Nikolaos Papaioannou · Compositions and methods for dengue virus chimeric constructs in vaccines Patent · US Government Health & Human Services · Dazostinag or conjugates thereof for treatment of neuroendocrine neoplasms Patent · Harry Huang, Lineberry Neil, Raizer Jeffrey, Appleman Vicky, Rosentrater Emily · Method for producing sterilized cell-containing containers, method for improving the sterilization efficiency of cell-containing containers, and recording media, computer and system used therein. Patent · Skan Japan ·

Where it bets · Where does Takeda place its bets?

Data · The evidence behind this radar

What do you want to know next?

Ask about anything in this radar's 6,046 documents.

Get the report

For your team, or for an AI tool.

Share it

Send your team the link to this radar.